179 related articles for article (PubMed ID: 32971103)
1. CtBP2 interacts with ZBTB18 to promote malignancy of glioblastoma.
Chen L; Wang L; Qin J; Wei DS
Life Sci; 2020 Dec; 262():118477. PubMed ID: 32971103
[TBL] [Abstract][Full Text] [Related]
2. Epigenetic Regulation of ZBTB18 Promotes Glioblastoma Progression.
Fedele V; Dai F; Masilamani AP; Heiland DH; Kling E; Gätjens-Sanchez AM; Ferrarese R; Platania L; Soroush D; Kim H; Nelander S; Weyerbrock A; Prinz M; Califano A; Iavarone A; Bredel M; Carro MS
Mol Cancer Res; 2017 Aug; 15(8):998-1011. PubMed ID: 28512252
[TBL] [Abstract][Full Text] [Related]
3. CtBP2 interacts with TGIF to promote the progression of esophageal squamous cell cancer through the Wnt/β‑catenin pathway.
Ju Q; Jiang M; Huang W; Yang Q; Luo Z; Shi H
Oncol Rep; 2022 Feb; 47(2):. PubMed ID: 34878149
[TBL] [Abstract][Full Text] [Related]
4. Overexpression of HOXC10 promotes glioblastoma cell progression to a poor prognosis via the PI3K/AKT signalling pathway.
Guan Y; He Y; Lv S; Hou X; Li L; Song J
J Drug Target; 2019 Jan; 27(1):60-66. PubMed ID: 29768063
[TBL] [Abstract][Full Text] [Related]
5. Up-regulated circular RNA hsa_circ_0067934 contributes to glioblastoma progression through activating PI3K-AKT pathway.
Xin J; Zhang XY; Sun DK; Tian LQ; Xu P
Eur Rev Med Pharmacol Sci; 2019 Apr; 23(8):3447-3454. PubMed ID: 31081099
[TBL] [Abstract][Full Text] [Related]
6. Potential mechanisms of microRNA-129-5p in inhibiting cell processes including viability, proliferation, migration and invasiveness of glioblastoma cells U87 through targeting FNDC3B.
Xu H; Hu Y; Qiu W
Biomed Pharmacother; 2017 Mar; 87():405-411. PubMed ID: 28068630
[TBL] [Abstract][Full Text] [Related]
7. Verbascoside inhibits progression of glioblastoma cells by promoting Let-7g-5p and down-regulating HMGA2 via Wnt/beta-catenin signalling blockade.
Jia WQ; Zhu JW; Yang CY; Ma J; Pu TY; Han GQ; Zou MM; Xu RX
J Cell Mol Med; 2020 Mar; 24(5):2901-2916. PubMed ID: 32000296
[TBL] [Abstract][Full Text] [Related]
8. ZWINT: A potential therapeutic biomarker in patients with glioblastoma correlates with cell proliferation and invasion.
Yang L; Han N; Zhang X; Zhou Y; Chen R; Zhang M
Oncol Rep; 2020 Jun; 43(6):1831-1844. PubMed ID: 32323832
[TBL] [Abstract][Full Text] [Related]
9. NAMPT: A potential prognostic and therapeutic biomarker in patients with glioblastoma.
Guo Q; Han N; Shi L; Yang L; Zhang X; Zhou Y; Yu S; Zhang M
Oncol Rep; 2019 Sep; 42(3):963-972. PubMed ID: 31322259
[TBL] [Abstract][Full Text] [Related]
10. Loss of endothelial programmed cell death 10 activates glioblastoma cells and promotes tumor growth.
Zhu Y; Zhao K; Prinz A; Keyvani K; Lambertz N; Kreitschmann-Andermahr I; Lei T; Sure U
Neuro Oncol; 2016 Apr; 18(4):538-48. PubMed ID: 26254477
[TBL] [Abstract][Full Text] [Related]
11. miR-504 suppresses mesenchymal phenotype of glioblastoma by directly targeting the FZD7-mediated Wnt-β-catenin pathway.
Liu Q; Guan Y; Li Z; Wang Y; Liu Y; Cui R; Wang Y
J Exp Clin Cancer Res; 2019 Aug; 38(1):358. PubMed ID: 31419987
[TBL] [Abstract][Full Text] [Related]
12. Long non-coding RNA CASP5 promotes the malignant phenotypes of human glioblastoma multiforme.
Zhou Y; Dai W; Wang H; Pan H; Wang Q
Biochem Biophys Res Commun; 2018 Jun; 500(4):966-972. PubMed ID: 29715460
[TBL] [Abstract][Full Text] [Related]
13. CtBP2 is an independent prognostic marker that promotes GLI1 induced epithelial-mesenchymal transition in hepatocellular carcinoma.
Zheng X; Song T; Dou C; Jia Y; Liu Q
Oncotarget; 2015 Feb; 6(6):3752-69. PubMed ID: 25686837
[TBL] [Abstract][Full Text] [Related]
14. LncRNA GAPLINC promotes the growth and metastasis of glioblastoma by sponging miR-331-3p.
Chen HH; Zong J; Wang SJ
Eur Rev Med Pharmacol Sci; 2019 Jan; 23(1):262-270. PubMed ID: 30657584
[TBL] [Abstract][Full Text] [Related]
15. Over-expressed lncRNA HOTAIRM1 promotes tumor growth and invasion through up-regulating HOXA1 and sequestering G9a/EZH2/Dnmts away from the HOXA1 gene in glioblastoma multiforme.
Li Q; Dong C; Cui J; Wang Y; Hong X
J Exp Clin Cancer Res; 2018 Oct; 37(1):265. PubMed ID: 30376874
[TBL] [Abstract][Full Text] [Related]
16. Silencing of PROS1 induces apoptosis and inhibits migration and invasion of glioblastoma multiforme cells.
Che Mat MF; Abdul Murad NA; Ibrahim K; Mohd Mokhtar N; Wan Ngah WZ; Harun R; Jamal R
Int J Oncol; 2016 Dec; 49(6):2359-2366. PubMed ID: 27840905
[TBL] [Abstract][Full Text] [Related]
17. MiR-203 downregulation is responsible for chemoresistance in human glioblastoma by promoting epithelial-mesenchymal transition via SNAI2.
Liao H; Bai Y; Qiu S; Zheng L; Huang L; Liu T; Wang X; Liu Y; Xu N; Yan X; Guo H
Oncotarget; 2015 Apr; 6(11):8914-28. PubMed ID: 25871397
[TBL] [Abstract][Full Text] [Related]
18. SECTM1 promotes the development of glioblastoma and mesenchymal transition by regulating the TGFβ1/Smad signaling pathway.
Yao Z; Zhang F; Qi C; Wang C; Mao M; Zhao C; Qi M; Wang Z; Zhou G; Jiang X; Xia H
Int J Biol Sci; 2024; 20(1):78-93. PubMed ID: 38164182
[No Abstract] [Full Text] [Related]
19. Repression of Septin9 and Septin2 suppresses tumor growth of human glioblastoma cells.
Xu D; Liu A; Wang X; Chen Y; Shen Y; Tan Z; Qiu M
Cell Death Dis; 2018 May; 9(5):514. PubMed ID: 29724999
[TBL] [Abstract][Full Text] [Related]
20. MicroRNA-139-3p suppresses growth and metastasis of glioblastoma via inhibition of NIN1/RPNI2 binding protein 1 homolog.
Shi L; Yuan Y; Li HY
Eur Rev Med Pharmacol Sci; 2019 May; 23(10):4264-4274. PubMed ID: 31173298
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
